Search

Author/Creator Mittal, Ravindra

1. Efficacy and safety of avanafil as compared with sildenafil in the treatment of erectile dysfunction: A randomized, double blind, multicenter clinical trial. (26th January 2022)

Authors:
Kumar, Manish; Pathade, Amey D; Gupta, S VijayaBhaskara; Goyal, Sanjay; Rath, Debadarshi; Thakre, Manish; Sanmukhani, Jayesh; Mittal, Ravindra
Journal:
International journal of urology
Issue:
Volume 29:Number 4(2022)
Page Start:
351
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Immunogenicity and safety of a novel MMR vaccine (live, freeze-dried) containing the Edmonston-Zagreb measles strain, the Hoshino mumps strain, and the RA 27/3 rubella strain: Results of a randomized, comparative, active controlled phase III clinical trial. Issue 7 (3rd July 2017)

Authors:
Sood, Ashwani; Mitra, Monjori; Joshi, Himanshu Arvind; Nayak, Uma Siddhartha; Siddaiah, Prashanth; Babu, T. Ramesh; Mahapatro, Samarendra; Sanmukhani, Jayesh; Gupta, Gaurav; Mittal, Ravindra; Glueck, Reinhard
Journal:
Human vaccines & immunotherapeutics
Issue:
Volume 13:Issue 7(2017)
Page Start:
1523
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Immunogenicity and safety of the first indigenously developed Indian tetravalent influenza vaccine (split virion) in healthy adults ≥ 18 years of age: A randomized, multicenter, phase II / III clinical trial. Issue 6 (3rd June 2018)

Authors:
Sharma, Shrikant; Singh, Veer Bahadur; Kumar, Sanjay; Prajapati, Vipul; Patel, Jitendra; Vukkala, Rajesh; Jangid, Sanjay Kumar; Sanmukhani, Jayesh; Gupta, Gaurav; Patel, Pradip; Mittal, Ravindra; Glueck, Reinhard
Journal:
Human vaccines & immunotherapeutics
Issue:
Volume 14:Issue 6(2018)
Page Start:
1362
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Immunogenicity and safety of the first indigenously developed Indian tetravalent influenza vaccine (split virion) in healthy children (6 months to 17 years of age): a randomized, multicenter, phase III clinical trial. Issue 3 (4th March 2021)

Authors:
Sarkar, Sumantra; Bokade, Chandrakant; Garg, Kapil; Kumar, Ravi; Sanmukhani, Jayesh; Mittal, Ravindra
Journal:
Human vaccines & immunotherapeutics
Issue:
Volume 17:Issue 3(2021)
Page Start:
681
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Safety and Immunogenicity of a DNA SARS-CoV-2 vaccine (ZyCoV-D): Results of an open-label, non-randomized phase I part of phase I/II clinical study by intradermal route in healthy subjects in India. (August 2021)

Authors:
Momin, Taufik; Kansagra, Kevinkumar; Patel, Hardik; Sharma, Sunil; Sharma, Bhumika; Patel, Jatin; Mittal, Ravindra; Sanmukhani, Jayesh; Maithal, Kapil; Dey, Ayan; Chandra, Harish; Rajanathan, Chozhavel TM; Pericherla, Hari PR; Kumar, Pawan; Narkhede, Anjali; Parmar, Deven
Journal:
EClinicalMedicine
Issue:
Volume 38(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗